According to the FDA, the improvement in AHI in participants with OSA is likely related to body weight reduction with Zepbound
Systolic blood pressure dropped by an average of 6 to 8 mmHg in the Phase 2 trial, which is a meaningful reduction
Clinical trials did not control for injection time because it does not significantly affect the drug is efficacy
Plus there is a value play here as well (i.e., look at how much valuable protein Im getting for the price.)
For 2 capsules: NatiCol Hydrolyzed Marine Collagen Type I (900 mg), Vitamin C (80 mg), Hyaluronic Acid (45 mg), Coenzyme Q10 (30 mg), Vitamin E (12 mg), Zinc (10 mg)
However, due to (i) rareness of the disease (unfamiliar to most neurologists), (ii) non-inclusion of GNE genetic testing for neurological indications, and (iii) non-specific symptoms at disease onset (foot-drop, balance impairment), the diagnosis of these patients is difficult and often delayed